Granite Harbor Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Granite Harbor Advisors's EW Position: Q3 2026 in Review
Granite Harbor Advisors increased its Edwards Lifesciences (EW) stake by 2.3% in Q3 2026, buying an estimated $8.98K and bringing the position to 4,589 shares worth $396K. The position accounts for 0.15% of the portfolio, ranked #94.
Granite Harbor Advisors first reported a position in EW in Q4 2022 and has held it in 16 quarters since. The position peaked at $411K in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Granite Harbor Advisors held 4,589 shares of Edwards Lifesciences worth $396K as of Q3 2026.
- Granite Harbor Advisors bought 101 Edwards Lifesciences shares in Q3 2026, an estimated $8.98K.
- Edwards Lifesciences made up 0.15% of Granite Harbor Advisors's portfolio in Q3 2026, its #94 holding.
- Granite Harbor Advisors first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 16 quarters since.
- Granite Harbor Advisors's Edwards Lifesciences position peaked at $411K in Q4 2025.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Granite Harbor Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.